|
US6090382A
(en)
*
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
ATE239041T1
(de)
*
|
1996-02-09 |
2003-05-15 |
Basf Ag |
Humane antikörper welche an humanen tnfalpha binden
|
|
US7115557B2
(en)
*
|
1998-09-25 |
2006-10-03 |
Sciaticon Ab |
Use of certain drugs for treating nerve root injury
|
|
US20050226845A1
(en)
*
|
2004-03-10 |
2005-10-13 |
Chih-Ping Liu |
Method of treatment using interferon-tau
|
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
|
US7199102B2
(en)
|
2000-08-24 |
2007-04-03 |
The Regents Of The University Of California |
Orally administered peptides synergize statin activity
|
|
US7723303B2
(en)
*
|
2000-08-24 |
2010-05-25 |
The Regents Of The University Of California |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
|
|
US7148197B2
(en)
*
|
2000-08-24 |
2006-12-12 |
The Regents Of The University Of California |
Orally administered small peptides synergize statin activity
|
|
CA2817619A1
(en)
|
2001-06-08 |
2002-12-08 |
Abbott Laboratories (Bermuda) Ltd. |
Methods of administering anti-tnf.alpha. antibodies
|
|
US20060241074A1
(en)
*
|
2001-08-14 |
2006-10-26 |
The General Hospital Corporation |
Methods for treatment of pain
|
|
MY140561A
(en)
*
|
2002-02-20 |
2009-12-31 |
Nycomed Gmbh |
Dosage form containing pde 4 inhibitor as active ingredient
|
|
US20040009172A1
(en)
*
|
2002-04-26 |
2004-01-15 |
Steven Fischkoff |
Use of anti-TNFalpha antibodies and another drug
|
|
US9028822B2
(en)
|
2002-06-28 |
2015-05-12 |
Domantis Limited |
Antagonists against TNFR1 and methods of use therefor
|
|
US20090280065A1
(en)
*
|
2006-04-10 |
2009-11-12 |
Willian Mary K |
Uses and Compositions for Treatment of Psoriasis
|
|
US20040131614A1
(en)
*
|
2002-07-19 |
2004-07-08 |
Abbott Biotechnology Ltd. |
Treatment of pulmonary disorders using TNFalpha inhibitor
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
US20050271660A1
(en)
|
2002-09-06 |
2005-12-08 |
Alexion Pharmaceuticals, Inc. |
Nebulization of monoclonal antibodies for treating pulmonary diseases
|
|
US9415102B2
(en)
*
|
2002-09-06 |
2016-08-16 |
Alexion Pharmaceuticals, Inc. |
High concentration formulations of anti-C5 antibodies
|
|
MY150740A
(en)
*
|
2002-10-24 |
2014-02-28 |
Abbvie Biotechnology Ltd |
Low dose methods for treating disorders in which tnf? activity is detrimental
|
|
US20040253237A1
(en)
*
|
2002-12-05 |
2004-12-16 |
Ian Walters |
Methods of treatment of ulcerative colitis with anti-CD3 antibodies
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
EA009985B1
(ru)
|
2003-03-10 |
2008-04-28 |
Никомед Гмбх |
Новый способ получения рофлумиласта
|
|
US7530968B2
(en)
*
|
2003-04-23 |
2009-05-12 |
Valeritas, Inc. |
Hydraulically actuated pump for long duration medicament administration
|
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
|
US20040229878A1
(en)
*
|
2003-05-13 |
2004-11-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of P38 kinase
|
|
US7344716B2
(en)
*
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
|
US8273347B2
(en)
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
|
US8361467B2
(en)
*
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
|
NZ545314A
(en)
|
2003-08-04 |
2009-03-31 |
Bristol Myers Squibb Co |
Methods for treating cardiovascular disease using a soluble CTLA4 molecule
|
|
US7396819B2
(en)
*
|
2003-08-08 |
2008-07-08 |
Virbac Corporation |
Anthelmintic formulations
|
|
EA200600921A1
(ru)
*
|
2003-11-06 |
2006-10-27 |
Селджин Корпорейшн |
Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний
|
|
US8895540B2
(en)
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
|
WO2005094210A2
(en)
*
|
2004-03-12 |
2005-10-13 |
The Hartz Mountain Corporation |
Multi-action anthelmintic formulations
|
|
TWI439284B
(zh)
*
|
2004-04-09 |
2014-06-01 |
艾伯維生物技術有限責任公司 |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
GB0414054D0
(en)
|
2004-06-23 |
2004-07-28 |
Owen Mumford Ltd |
Improvements relating to automatic injection devices
|
|
TWI307630B
(en)
*
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
|
US9089636B2
(en)
|
2004-07-02 |
2015-07-28 |
Valeritas, Inc. |
Methods and devices for delivering GLP-1 and uses thereof
|
|
US20060046961A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Mckay William F |
Controlled and directed local delivery of anti-inflammatory compositions
|
|
US20060205669A1
(en)
*
|
2004-09-16 |
2006-09-14 |
The Regents Of The University Of California |
G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
|
|
DE102004046235A1
(de)
*
|
2004-09-22 |
2006-03-30 |
Altana Pharma Ag |
Arzneimittelzubereitung
|
|
WO2006041970A2
(en)
*
|
2004-10-08 |
2006-04-20 |
Abbott Biotechnology Ltd. |
Treatment of respiratory syncytial virus (rsv) infection
|
|
KR20070089996A
(ko)
*
|
2004-12-06 |
2007-09-04 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
세동맥의 구조 및 기능의 개선 방법
|
|
ES2421916T3
(es)
*
|
2005-03-16 |
2013-09-06 |
Nycomed Gmbh |
Forma farmacéutica de sabor enmascarado que contiene roflumilast
|
|
US7431927B2
(en)
|
2005-03-24 |
2008-10-07 |
Epitomics, Inc. |
TNFα-neutralizing antibodies
|
|
AU2006230419A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Targeted Genetics Corporation |
Methods for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders
|
|
AU2006242651B2
(en)
*
|
2005-04-29 |
2013-05-16 |
The Regents Of The University Of California |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
|
|
US20080293639A1
(en)
*
|
2005-04-29 |
2008-11-27 |
The Regents Of The University Of California |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
|
|
JP5757495B2
(ja)
*
|
2005-05-16 |
2015-07-29 |
アッヴィ バイオテクノロジー リミテッド |
びらん性多発性関節炎の治療のためのｔｎｆ阻害剤の使用
|
|
AU2012254978C1
(en)
*
|
2005-05-16 |
2017-06-01 |
Abbvie Biotechnology Ltd |
Use of TNF inhibitor for treatment of erosive polyarthritis
|
|
US20060286142A1
(en)
*
|
2005-06-03 |
2006-12-21 |
Biohesion, Inc. |
Gold surfaces coated with a thermostable chemically resistant polypeptide layer and applications thereof
|
|
JP2008543839A
(ja)
|
2005-06-14 |
2008-12-04 |
アムジェン インコーポレーテッド |
自己緩衝タンパク質製剤
|
|
US20070041905A1
(en)
|
2005-08-19 |
2007-02-22 |
Hoffman Rebecca S |
Method of treating depression using a TNF-alpha antibody
|
|
TWI333959B
(en)
*
|
2005-08-31 |
2010-12-01 |
Academia Sinica |
Methods and reagents for the analysis and purification of polysaccharides
|
|
US7943134B2
(en)
|
2005-08-31 |
2011-05-17 |
Academia Sinica |
Compositions and methods for identifying response targets and treating flavivirus infection responses
|
|
TW201337266A
(zh)
|
2005-11-01 |
2013-09-16 |
Abbott Biotech Ltd |
利用生物標記診斷關節黏連脊椎炎之方法及組合物
|
|
RU2442793C2
(ru)
|
2005-11-30 |
2012-02-20 |
Эбботт Лэборетриз |
АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
|
|
PL1976877T5
(pl)
|
2005-11-30 |
2017-09-29 |
Abbvie Inc |
Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
|
|
US8795668B2
(en)
*
|
2005-12-23 |
2014-08-05 |
The Regents Of The University Of Michigan |
Methods for treating pulmonary fibrosis
|
|
CN103239773B
(zh)
|
2006-03-30 |
2015-08-26 |
瓦莱里塔斯公司 |
多筒式流体递送器械
|
|
CN102391358B
(zh)
|
2006-04-05 |
2016-08-10 |
艾伯维生物技术有限公司 |
抗体纯化
|
|
US20090317399A1
(en)
*
|
2006-04-10 |
2009-12-24 |
Pollack Paul F |
Uses and compositions for treatment of CROHN'S disease
|
|
WO2007120823A2
(en)
*
|
2006-04-10 |
2007-10-25 |
Abbott Biotechnology Ltd. |
Uses and compositions for treatment of psoriasis
|
|
US9605064B2
(en)
|
2006-04-10 |
2017-03-28 |
Abbvie Biotechnology Ltd |
Methods and compositions for treatment of skin disorders
|
|
US9399061B2
(en)
*
|
2006-04-10 |
2016-07-26 |
Abbvie Biotechnology Ltd |
Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis
|
|
US20080118496A1
(en)
*
|
2006-04-10 |
2008-05-22 |
Medich John R |
Uses and compositions for treatment of juvenile rheumatoid arthritis
|
|
WO2008063213A2
(en)
|
2006-04-10 |
2008-05-29 |
Abbott Biotechnology Ltd. |
Uses and compositions for treatment of psoriatic arthritis
|
|
WO2007120626A2
(en)
|
2006-04-10 |
2007-10-25 |
Abbott Biotechnology Ltd. |
Uses and compositions for treatment of ankylosing spondylitis
|
|
US20080131374A1
(en)
*
|
2006-04-19 |
2008-06-05 |
Medich John R |
Uses and compositions for treatment of rheumatoid arthritis
|
|
EP2021016B1
(en)
*
|
2006-04-21 |
2016-01-06 |
Janssen Biotech, Inc. |
Cxcl-13 antagonists and tnf-alpha antagonists for use in a combination therapy
|
|
US20080311043A1
(en)
*
|
2006-06-08 |
2008-12-18 |
Hoffman Rebecca S |
Uses and compositions for treatment of psoriatic arthritis
|
|
US20100021451A1
(en)
|
2006-06-08 |
2010-01-28 |
Wong Robert L |
Uses and compositions for treatment of ankylosing spondylitis
|
|
CN103316402A
(zh)
*
|
2006-06-30 |
2013-09-25 |
艾伯维生物技术有限公司 |
自动注射装置
|
|
EP2684895A1
(en)
|
2006-10-27 |
2014-01-15 |
AbbVie Biotechnology Ltd |
Crystalline anti-hTNFalpha antibodies
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
CN101200465B
(zh)
*
|
2006-12-11 |
2010-12-29 |
和记黄埔医药（上海）有限公司 |
一种十氢化萘类化合物及其医药用途
|
|
US8895004B2
(en)
|
2007-02-27 |
2014-11-25 |
AbbVie Deutschland GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
CA2681752A1
(en)
|
2007-03-29 |
2008-10-09 |
Abbott Laboratories |
Crystalline anti-human 1l-12 antibodies
|
|
US20080254011A1
(en)
*
|
2007-04-11 |
2008-10-16 |
Peter Rothschild |
Use of selected lactic acid bacteria for reducing atherosclerosis
|
|
WO2008141511A1
(fr)
*
|
2007-05-22 |
2008-11-27 |
Human Antibodomics (Shanghai) Inc. |
ANTICORPS MONOCLONAL HUMAIN ANTI-TNFα ET SON UTILISATION
|
|
EP2165194A4
(en)
*
|
2007-05-31 |
2010-09-08 |
Abbott Lab |
BIOMARKERS FOR PREDICTING RESPONSABILITY TO TNF ALPHA INHIBITORS IN AUTOIMMUNE DISEASES
|
|
EP2171451A4
(en)
*
|
2007-06-11 |
2011-12-07 |
Abbott Biotech Ltd |
METHOD FOR TREATING JUVENILIAN IDIOPATHIC ARTHRITIS
|
|
CA2693771A1
(en)
*
|
2007-07-13 |
2009-01-22 |
Abbott Biotechnology Ltd. |
Methods and compositions for pulmonary administration of a tnf.alpha. inhibitor
|
|
EP2184997A4
(en)
*
|
2007-07-31 |
2010-11-03 |
Univ New York |
DIAGNOSIS AND TREATMENT METHODS FOR THE CHARACTERIZATION OF BACTERIAL MICROORGANISMS IN SKIN DISEASES
|
|
MX2010001488A
(es)
|
2007-08-08 |
2010-03-01 |
Abbott Lab |
Composiciones y metodos para cristalizar anticuerpos.
|
|
AU2008296487A1
(en)
|
2007-08-28 |
2009-03-12 |
The Uab Research Foundation |
Synthetic apolipoprotein E mimicking polypeptides and methods of use
|
|
JP2010538005A
(ja)
|
2007-08-28 |
2010-12-09 |
ユーエービー リサーチ ファウンデーション |
合成アポリポ蛋白質ｅ模倣ポリペプチドおよび使用方法
|
|
WO2009052140A1
(en)
*
|
2007-10-15 |
2009-04-23 |
Alcon Research, Ltd. |
Use of tnf receptor antagonists for treating dry eye
|
|
WO2009061830A1
(en)
*
|
2007-11-06 |
2009-05-14 |
Massachusetts Eye & Ear Infirmary |
Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor
|
|
US8420081B2
(en)
|
2007-11-30 |
2013-04-16 |
Abbvie, Inc. |
Antibody formulations and methods of making same
|
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
|
MX2010007393A
(es)
*
|
2008-01-03 |
2010-11-09 |
Abbott Biotech Ltd |
Anticipacion de eficacia a largo plazo de un compuesto en el tratamiento de psoriasis.
|
|
SG2013054218A
(en)
|
2008-01-15 |
2014-10-30 |
Abbott Gmbh & Co Kg |
Powdered protein compositions and methods of making same
|
|
US9365644B2
(en)
*
|
2008-04-23 |
2016-06-14 |
Epitomics, Inc. |
Anti-TNFα antibody
|
|
CA2932207A1
(en)
*
|
2008-10-20 |
2010-12-09 |
Abbvie Inc. |
Isolation and purification of antibodies using protein a affinity chromatography
|
|
RU2595379C2
(ru)
*
|
2009-04-16 |
2016-08-27 |
АббВай Биотерапеутикс Инк. |
АНТИТЕЛА ПРОТИВ TNF-α И ИХ ПРИМЕНЕНИЯ
|
|
AU2010242972B2
(en)
|
2009-04-29 |
2015-07-09 |
Abbvie Biotechnology Ltd |
Automatic injection device
|
|
US20100278822A1
(en)
*
|
2009-05-04 |
2010-11-04 |
Abbott Biotechnology, Ltd. |
Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
|
|
EP2512558A4
(en)
|
2009-12-15 |
2014-08-13 |
Abbvie Biotechnology Ltd |
IMPROVED TRIP KNOB FOR AUTOMATIC INJECTION DEVICE
|
|
WO2011084714A2
(en)
*
|
2009-12-17 |
2011-07-14 |
Biogen Idec Ma Inc. |
STABILIZED ANTI-TNF-ALPHA scFv MOLECULES OR ANTI-TWEAK scFv MOLECULES AND USES THEREOF
|
|
WO2011130377A2
(en)
|
2010-04-15 |
2011-10-20 |
Abbott Laboratories |
Amyloid-beta binding proteins
|
|
KR102071212B1
(ko)
|
2010-04-21 |
2020-01-30 |
애브비 바이오테크놀로지 리미티드 |
치료제의 제어된 전달을 위한 착용형 자동 주사 디바이스
|
|
MX2012014080A
(es)
|
2010-06-03 |
2013-05-01 |
Abbvie Biotechnology Ltd |
Usos y composiciones para el tratamiento de hidradenitis superativa (hs).
|
|
US9062101B2
(en)
|
2010-08-14 |
2015-06-23 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
|
TWI603739B
(zh)
|
2010-11-11 |
2017-11-01 |
艾伯維生物技術有限責任公司 |
具有增進高濃度之抗－ＴＮＦα抗體之液體調配物
|
|
SG192119A1
(en)
|
2011-01-24 |
2013-08-30 |
Abbvie Biotechnology Ltd |
Automatic injection devices having overmolded gripping surfaces
|
|
ES2711100T3
(es)
*
|
2011-03-07 |
2019-04-30 |
Celgene Corp |
Métodos para tratar enfermedades usando compuestos isoindolina
|
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
CN108014340A
(zh)
*
|
2011-04-12 |
2018-05-11 |
莫伊莱麦屈克斯公司 |
用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病的组合物和方法
|
|
WO2012149197A2
(en)
|
2011-04-27 |
2012-11-01 |
Abbott Laboratories |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
|
JP5976815B2
(ja)
*
|
2011-09-23 |
2016-08-24 |
ヴェストファーリッシュ ヴィルヘルム−ユニバーシテート ミュンスター |
乾癬の治療におけるエルシニア属外部タンパク質Ｍ（ＹｏｐＭ）
|
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
|
US9150645B2
(en)
|
2012-04-20 |
2015-10-06 |
Abbvie, Inc. |
Cell culture methods to reduce acidic species
|
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
|
US9249182B2
(en)
|
2012-05-24 |
2016-02-02 |
Abbvie, Inc. |
Purification of antibodies using hydrophobic interaction chromatography
|
|
WO2013191352A1
(en)
|
2012-06-21 |
2013-12-27 |
Hanall Biopharma Co., Ltd. |
New uses of modified human tumor necrosis factor receptor-1 polypeptide
|
|
HK1211981A1
(en)
|
2012-09-02 |
2016-06-03 |
Abbvie Inc. |
Methods to control protein heterogeneity
|
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
|
EP4397314B1
(en)
*
|
2012-10-22 |
2025-12-03 |
Stealth BioTherapeutics Inc. |
Treatment of left ventricular remodeling
|
|
US20140255403A1
(en)
*
|
2013-03-06 |
2014-09-11 |
Hadasit Medical Research Services & Development Ltd. |
Oral composition comprising a tnf antagonist and use thereof
|
|
SG11201507230PA
(en)
|
2013-03-12 |
2015-10-29 |
Abbvie Inc |
Human antibodies that bind human tnf-alpha and methods of preparing the same
|
|
WO2014159579A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbvie Inc. |
MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
|
|
WO2014151878A2
(en)
|
2013-03-14 |
2014-09-25 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
|
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
|
US9726677B2
(en)
|
2013-03-15 |
2017-08-08 |
Intermune, Inc. |
Proteomic IPF markers
|
|
US9827181B2
(en)
*
|
2013-06-05 |
2017-11-28 |
Industrial Technology Research Institute |
Method and pharmaceutical composition for hair growth
|
|
CN104341502B
(zh)
*
|
2013-08-09 |
2016-04-27 |
北京天成新脉生物技术有限公司 |
低免疫原性抗TNF-α全人源单抗及其应用
|
|
PL226431B1
(pl)
|
2013-08-23 |
2017-07-31 |
Inst Biochemii I Biofizyki Polskiej Akademii Nauk |
Cząsteczka miRNA do zastosowania do wytwarzania leku do zmniejszania reakcji zapalnej lub zapobiegania zwiększaniu się reakcji zapalnej organizmu
|
|
US9598667B2
(en)
|
2013-10-04 |
2017-03-21 |
Abbvie Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
|
AU2014337263B2
(en)
|
2013-10-16 |
2019-12-12 |
Outlook Therapeutics, Inc. |
Buffer formulations for enhanced antibody stability
|
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
|
US20150139988A1
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
|
CN103961694A
(zh)
*
|
2014-04-18 |
2014-08-06 |
陶惠人 |
基于p-硝基苯丙氨酸插入法构建的骨质疏松疫苗
|
|
US10351621B2
(en)
|
2014-06-24 |
2019-07-16 |
Immunomedics, Inc. |
Anti-histone therapy in acute kidney injury
|
|
US9580495B2
(en)
|
2014-06-24 |
2017-02-28 |
Immunomedics, Inc. |
Anti-histone therapy for vascular necrosis in severe glomerulonephritis
|
|
US9764122B2
(en)
|
2014-07-25 |
2017-09-19 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having an occluding member
|
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
|
JP7081923B2
(ja)
|
2014-07-31 |
2022-06-07 |
ユーエイビー リサーチ ファンデーション |
アポｅ模倣ペプチド及び血漿コレステロールを取り除くためのより高い効果
|
|
CN108064308B
(zh)
|
2014-11-05 |
2023-06-09 |
豪夫迈·罗氏有限公司 |
细菌中产生双链蛋白的方法
|
|
RU2739500C2
(ru)
|
2014-11-05 |
2020-12-25 |
Дженентек, Инк. |
Способы получения двуцепочечных белков в бактериях
|
|
WO2016073853A1
(en)
|
2014-11-06 |
2016-05-12 |
Scholar Rock, Inc. |
Anti-pro/latent-myostatin antibodies and uses thereof
|
|
US10235904B2
(en)
*
|
2014-12-01 |
2019-03-19 |
Truinject Corp. |
Injection training tool emitting omnidirectional light
|
|
EP3247718B1
(en)
|
2015-01-21 |
2021-09-01 |
Outlook Therapeutics, Inc. |
Modulation of charge variants in a monoclonal antibody composition
|
|
US10465224B2
(en)
|
2015-02-03 |
2019-11-05 |
Mayo Foundation For Medical Education And Research |
Methods and materials for assessing and treating arthritis
|
|
AU2016239949A1
(en)
|
2015-03-31 |
2017-09-07 |
Sorriso Pharmaceuticals, Inc. |
Peptide construct having a protease-cleavable linker
|
|
EP3277719B1
(en)
|
2015-03-31 |
2022-03-16 |
Sorriso Pharmaceuticals, Inc. |
Polypeptides
|
|
WO2016156468A1
(en)
|
2015-03-31 |
2016-10-06 |
Vhsquared Limited |
Polypeptides
|
|
EP3078675A1
(en)
|
2015-04-10 |
2016-10-12 |
Ares Trading S.A. |
Induction dosing regimen for the treatment of tnf alpha mediated disorders
|
|
AU2016275149A1
(en)
|
2015-06-12 |
2018-01-04 |
Georgia State University Research Foundation |
Compositions and methods for treating opioid tolerance
|
|
CN105175529A
(zh)
*
|
2015-07-16 |
2015-12-23 |
中国科学院海洋研究所 |
一种鱼类肿瘤坏死因子家族蛋白的重组蛋白及其应用
|
|
JP2018527903A
(ja)
*
|
2015-07-22 |
2018-09-27 |
スカラー ロック インコーポレイテッドＳｃｈｏｌａｒ Ｒｏｃｋ，Ｉｎｃ． |
Ｇｄｆ１１結合タンパク質およびその使用
|
|
EA038146B1
(ru)
|
2015-09-15 |
2021-07-13 |
Сколар Рок, Инк. |
Антитела к про-/латентному миостатину и их применения
|
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
|
CN115814077A
(zh)
|
2016-01-08 |
2023-03-21 |
供石公司 |
抗-原肌生长抑制素/潜伏肌生长抑制素抗体及其使用方法
|
|
EP3411401A1
(en)
|
2016-02-03 |
2018-12-12 |
Oncobiologics, Inc. |
Buffer formulations for enhanced antibody stability
|
|
US10465003B2
(en)
*
|
2016-02-05 |
2019-11-05 |
Janssen Biotech, Inc. |
Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
|
|
PL4218804T3
(pl)
|
2016-06-13 |
2026-05-25 |
Scholar Rock, Inc. |
Stosowanie inhibitorów miostatyny i terapii skojarzonych
|
|
USD802755S1
(en)
|
2016-06-23 |
2017-11-14 |
Warsaw Orthopedic, Inc. |
Drug pellet cartridge
|
|
WO2018045213A1
(en)
*
|
2016-09-02 |
2018-03-08 |
180 Therapeutics Lp |
Method of treating systemic fibrotic disorders using an il-33/tnf bispecific antibody
|
|
WO2018045258A1
(en)
*
|
2016-09-02 |
2018-03-08 |
The University Of Chicago |
TREATMENT OF TNF-alpha CYTOTOXICITY
|
|
WO2018060453A1
(en)
|
2016-09-30 |
2018-04-05 |
Vhsquared Limited |
Compositions
|
|
ES3064802T3
(en)
|
2016-10-21 |
2026-04-29 |
Amgen Inc |
Pharmaceutical formulations and methods of making the same
|
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
|
AU2017378393B2
(en)
*
|
2016-12-14 |
2023-03-09 |
Bt Bidco, Inc. |
Treatment of a disease of the gastrointestinal tract with a TNF inhibitor
|
|
EP3824906A1
(en)
|
2016-12-21 |
2021-05-26 |
Amgen Inc. |
Anti-tnf alpha antibody formulations
|
|
HRP20230308T1
(hr)
|
2017-01-06 |
2023-05-12 |
Scholar Rock, Inc. |
Liječenje metaboličkih bolesti putem inhibiranja aktivacije miostatina
|
|
KR101946884B1
(ko)
*
|
2017-04-25 |
2019-02-13 |
고려대학교 산학협력단 |
대사체 분석을 이용한 베체트병의 진단방법
|
|
CN110545863B
(zh)
*
|
2017-04-25 |
2021-06-01 |
群康生技股份有限公司 |
注射笔
|
|
CN110944689B
(zh)
|
2017-06-07 |
2022-12-09 |
施菲姆德控股有限责任公司 |
血管内流体运动设备、系统和使用方法
|
|
KR20190024572A
(ko)
*
|
2017-08-30 |
2019-03-08 |
(주)셀트리온 |
TNFα 관련 질환을 치료하기 위한 피하 투여 요법
|
|
CN107362351B
(zh)
*
|
2017-09-04 |
2020-11-10 |
上海市儿童医院 |
Il-36r的拮抗剂在制备镇痛药物中的应用
|
|
WO2019094963A1
(en)
|
2017-11-13 |
2019-05-16 |
Shifamed Holdings, Llc |
Intravascular fluid movement devices, systems, and methods of use
|
|
WO2019152875A1
(en)
|
2018-02-01 |
2019-08-08 |
Shifamed Holdings, Llc |
Intravascular blood pumps and methods of use and manufacture
|
|
WO2019204646A1
(en)
|
2018-04-18 |
2019-10-24 |
Xencor, Inc. |
Lag-3 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and lag-3 antigen binding domains
|
|
CN108588040B
(zh)
*
|
2018-06-08 |
2021-06-15 |
中国医学科学院病原生物学研究所 |
重组MtMetRS、其晶体及它们在制备抗结核药物中的应用
|
|
US20210347881A1
(en)
*
|
2018-07-25 |
2021-11-11 |
Rush University Medical Center |
Inhibition of kidney disease relapse by targeted cytokine depletion
|
|
US12161857B2
(en)
|
2018-07-31 |
2024-12-10 |
Shifamed Holdings, Llc |
Intravascular blood pumps and methods of use
|
|
WO2020073047A1
(en)
|
2018-10-05 |
2020-04-09 |
Shifamed Holdings, Llc |
Intravascular blood pumps and methods of use
|
|
US12232867B2
(en)
*
|
2018-10-26 |
2025-02-25 |
Abbott Diabetes Care Inc. |
Methods, devices, and systems for physiological parameter analysis
|
|
US11618776B2
(en)
|
2018-12-20 |
2023-04-04 |
Xencor, Inc. |
Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domains
|
|
CN109998488B
(zh)
*
|
2019-04-13 |
2022-08-02 |
中国医学科学院北京协和医院 |
克罗恩病和肠道溃疡型淋巴瘤的鉴别模型及构建方法
|
|
WO2020236636A1
(en)
*
|
2019-05-17 |
2020-11-26 |
Celgene Car Llc |
Methods of treating a mk2-mediated disorder
|
|
CN114340732A
(zh)
*
|
2019-06-17 |
2022-04-12 |
梅约医学教育与研究基金会 |
普氏菌属制剂以及治疗慢性阻塞性肺部疾病(copd)和其他肺部疾病
|
|
JP7692844B2
(ja)
|
2019-06-21 |
2025-06-16 |
ソリッソ ファーマシューティカルズ，インク． |
ポリペプチド
|
|
CA3144566A1
(en)
|
2019-06-21 |
2020-12-24 |
Sorriso Pharmaceuticals, Inc. |
Polypeptides
|
|
US12570736B2
(en)
|
2019-06-21 |
2026-03-10 |
Sorriso Pharmaceuticals, Inc. |
Compositions
|
|
US11964145B2
(en)
|
2019-07-12 |
2024-04-23 |
Shifamed Holdings, Llc |
Intravascular blood pumps and methods of manufacture and use
|
|
WO2021016372A1
(en)
|
2019-07-22 |
2021-01-28 |
Shifamed Holdings, Llc |
Intravascular blood pumps with struts and methods of use and manufacture
|
|
EP4010046B1
(en)
|
2019-08-07 |
2026-07-15 |
Supira Medical, Inc. |
Catheter blood pumps and collapsible pump housings
|
|
WO2021038097A1
(en)
*
|
2019-08-30 |
2021-03-04 |
Vestlandets Innovasjonsselskap As |
Method for the treatment of chronic fatigue syndrome using an inhibitory or cytotoxic agent against plasma cells
|
|
EP4034192B1
(en)
|
2019-09-25 |
2025-12-24 |
Supira Medical, Inc. |
Intravascular blood pump systems and methods of use and control thereof
|
|
EP4782050A1
(en)
|
2019-09-25 |
2026-07-29 |
Supira Medical, Inc. |
Catheter blood pumps and collapsible blood conduits
|
|
WO2021062270A1
(en)
|
2019-09-25 |
2021-04-01 |
Shifamed Holdings, Llc |
Catheter blood pumps and collapsible pump housings
|
|
US20230025003A1
(en)
*
|
2019-10-18 |
2023-01-26 |
BioZipcode, Inc. |
Diabetes therapy targeting abnormal stem cells
|
|
EP4072650A4
(en)
|
2019-12-11 |
2024-01-10 |
Shifamed Holdings, LLC |
Descending aorta and vena cava blood pumps
|
|
WO2021127503A1
(en)
|
2019-12-19 |
2021-06-24 |
Shifamed Holdings, Llc |
Intravascular blood pumps, motors, and fluid control
|
|
TWI807338B
(zh)
*
|
2020-06-26 |
2023-07-01 |
美商美國禮來大藥廠 |
結合ＴＧＦ-α及表皮調節素（ＥＰＩＲＥＧＵＬＩＮ）之抗體於治療疼痛之用途
|
|
AU2021397808A1
(en)
*
|
2020-12-09 |
2023-07-06 |
Servatus Ltd |
Combination therapy for inflammatory disorders of the joints
|
|
TWI859538B
(zh)
|
2021-05-21 |
2024-10-21 |
美商美國禮來大藥廠 |
靶向表皮調節素(epiregulin)之化合物及方法
|
|
CN120677175A
(zh)
|
2022-12-22 |
2025-09-19 |
供石公司 |
肌生成抑制蛋白活化的选择性和强效抑制剂
|